Atossa Therapeutics is testing whether one estrogen receptor molecule can span two very different diseases: breast cancer and Duchenne muscular dystrophy. The c

Atossa Therapeutics is testing whether one estrogen receptor molecule can span two very different diseases: breast cancer and Duchenne muscular dystrophy. The company says newly published reviews support a broader push to repurpose receptor biology.